RTICBM-74 Is a Brain-Penetrant Cannabinoid Receptor Subtype 1 Allosteric Modulator that Reduces Alcohol Intake in Rats | Journal of Pharmacology and Experimental Therapeutics
Noribogaine is a G-protein biased κ-opioid receptor agonist – topic of research paper in Biological sciences. Download scholarly article PDF and read for free on CyberLeninka open science hub.
Buprenorphine: A Promising Yet Overlooked Tool
Kappa Opiate Receptor Agonist - an overview | ScienceDirect Topics
Kappa Opiate Receptor - an overview | ScienceDirect Topics
Diverse Kappa Opioid Receptor Agonists: Relationships Between Signaling and Behavior
Κ-opioid receptor - an overview | ScienceDirect Topics
Κ-opioid receptor - an overview | ScienceDirect Topics
Buprenorphine: A Promising Yet Overlooked Tool
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
κ-opioid receptor - Wikipedia
The Kappa Opioid Receptor | SpringerLink
Stress and opioids: Role of opioids in modulating stress-related behavior and effect of stress on morphine conditioned place preference - ScienceDirect
The molecular neurobiology and neuropathology of opioid use disorder - ScienceDirect
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
Mary Jeanne Kreek, M.D. Patrick E. and Beatrice M. Haggerty Professor - ppt download
Kinase cascades and ligand-directed signaling at the kappa opioid receptor. - Abstract - Europe PMC
Buprenorphine: A Promising Yet Overlooked Tool
κ-opioid receptor - Wikipedia
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
The molecular neurobiology and neuropathology of opioid use disorder - ScienceDirect
The molecular neurobiology and neuropathology of opioid use disorder - ScienceDirect
IJMS | Free Full-Text | GPCR-Based Dopamine Sensors—A Detailed Guide to Inform Sensor Choice for In Vivo Imaging | HTML
Frontiers | Cannabinoid Receptor 1 Inhibition in Chronic Kidney Disease: A New Therapeutic Toolbox
Frontiers | Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)